Exparel recall: Subpotent
EXPAREL (bupivacaine liposome injectable suspension), 1.3%, 266 mg/20 mL (13.3 mg/mL) single use vials, INVESTIGATIONAL USE. For Infiltration Only.…
Why was Exparel recalled?
Subpotent; bupivacaine
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #11-2005 Control #23542 Manufacture Date: 05Dec11 2011-L-009
- Product
- EXPAREL (bupivacaine liposome injectable suspension), 1.3%, 266 mg/20 mL (13.3 mg/mL) single use vials, INVESTIGATIONAL USE. For Infiltration Only.…
- Recalling firm
- Pacira Pharmaceuticals, Inc.
- Quantity
- 324 vials
- Distribution
- Nationwide distribution: AZ, DC, FL, GA, MA, NJ, NY, OH, and TX.
- Recall date
- March 6, 2013
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)